International Journal of Antimicrobial Agents
Volume 36, Issue 1 , Pages 43-49 , July 2010

Efficacy of artemisinin in experimental visceral leishmaniasis

Received 23 July 2009 ,Accepted 3 March 2010.

References 

  1. World Health Organization. Report of the Fifth Consultative Meeting on Leishmania/HIV Coinfection. Addis Ababa, Ethiopia, 20-22 March 2007. Geneva, Switzerland: WHO; 2007. WHO/CDS/NTD/IDM/2007.5.
  2. Sundar S, Chatterjee M. Visceral leishmaniasis—current therapeutic modalities. Indian J Med Res. 2006;123:345–352
  3. Yardley V, Croft SL. A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis. Int J Antimicrob Agents. 2000;13:243–248
  4. Kaye PM, Svensson M, Ato M, Maroof A, Polley R, Stager S, et al. The immunopathology of experimental visceral leishmaniasis. Immunol Rev. 2004;201:239–253
  5. Murray HW. Clinical and experimental advances in treatment of visceral leishmaniasis. Antimicrob Agents Chemother. 2001;45:2185–2197
  6. Ganguly S, Bandyopadhyay S, Bera A, Chatterjee M. Anti-promastigote activity of an ethanolic extract of leaves of Artemisia indica. Indian J Pharmacol. 2006;38:64–65
  7. Sen R, Bandyopadhyay S, Dutta A, Mandal G, Ganguly S, Saha P, et al. Artemisinin triggers induction of cell-cycle arrest and apoptosis in Leishmania donovani promastigotes. J Med Microbiol. 2007;56:1213–1218
  8. Avery MA, Muraleedharan KM, Desai PV, Bandyopadhyaya AK, Furtado MM, Tekwani BL. Structure–activity relationships of the antimalarial agent artemisinin. 8. Design, synthesis, and CoMFA studies toward the development of artemisinin-based drugs against leishmaniasis and malaria. J Med Chem. 2003;46:4244–4258
  9. Yang DM, Liew FY. Effects of qinghaosu (artemisinin) and its derivatives on experimental cutaneous leishmaniasis. Parasitology. 1993;106:7–11
  10. Ganguly S, Bandyopadhyay S, Sarkar A, Chatterjee M. Development of a semi-automated colorimetric assay for screening anti-leishmanial agents. J Microbiol Methods. 2006;66:79–86
  11. Sarkar D, Saha P, Gamre S, Bhattacharjee S, Hariharan C, Ganguly S, et al. Anti-inflammatory effect of allylpyrocatechol in LPS-induced macrophages is mediated by suppression of iNOS and COX-2 via the NF-κB pathway. Int Immunopharmacol. 2008;8:1264–1271
  12. Ganguly S, Mula S, Chattopadhyay S, Chatterjee M. An ethanol extract of Piper betle Linn. mediates its anti-inflammatory activity via down-regulation of nitric oxide. J Pharm Pharmacol. 2007;59:711–718
  13. Stauber LA. Host resistance to Khartoum strain of Leishmania donovani. Rice Institute Pamphlet. 1958;45:80–83
  14. Bhattacharjee S, Gupta G, Bhattacharya P, Mukherjee A, Mujumdar SB, Pal A, et al. Quassin alters the immunological patterns of murine macrophages through generation of nitric oxide to exert antileishmanial activity. J Antimicrob Chemother. 2009;63:317–324
  15. Murray HW, Nathan CF. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J Exp Med. 1999;189:741–746
  16. Carrion J, Nieto A, Iborra S, Iniesta V, Soto M, Folgueira C, et al. Immunohistological features of visceral leishmaniasis in BALB/c mice. Parasite Immunol. 2006;28:173–183
  17. Haldar AK, Banerjee S, Naskar K, Kalita D, Islam NS, Roy S. Sub-optimal dose of sodium antimony gluconate (SAG)–diperoxovanadate combination clears organ parasites from BALB/c mice infected with antimony resistant Leishmania donovani by expanding antileishmanial T-cell repertoire and increasing IFN-γ to IL-10 ratio. Exp Parasitol. 2009;122:145–154
  18. Ying MA, Dian-mei L, Xiao-jun LU, Lin L, Xiao-su H. Activity of dihydroartemisinin against Leishmania donovani both in vitro and in vivo. Chin Med J (Engl). 2004;117:1271–1273
  19. Danso-Appiah A, Garner P, Olliaro PL, Utzinger J. Treatment of urinary schistosomiasis: methodological issues and research needs identified through a Cochrane systematic review. Parasitology. 2009;136:1837–1849
  20. Keiser J, Shu-Hua X, Jian X, Zhen-San C, Odermatt P, Tesana S. Effect of artesunate and artemether against Clonorchis sinensis and Opisthorchis viverrini in rodent models. Int J Antimicrob Agents. 2006;28:370–373
  21. Murray HW, Delph-Etienne S. Visceral leishmanicidal activity of hexadecylphosphocholine (miltefosine) in mice deficient in T cells and activated macrophage microbicidal mechanisms. J Infect Dis. 2000;181:795–799
  22. Escobar P, Yardley V, Croft SL. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice. Antimicrob Agents Chemother. 2001;45:1872–1875
  23. Meissner U, Jüttner S, Röllinghoff M, Gessner A. Cyclosporin A-mediated killing of Leishmania major by macrophages is independent of reactive nitrogen and endogenous TNF-α and is not inhibited by IL-10 and 13. Parasitol Res. 2003;89:221–227
  24. Tempone AG, Taniwaki NN, Reimão JQ. Antileishmanial activity and ultrastructural alterations of Leishmania (L.) chagasi treated with the calcium channel blocker nimodipine. Parasitol Res. 2009;105:499–505
  25. Soares DC, Pereira CG, Meireles MA, Saraiva EM. Leishmanicidal activity of a supercritical fluid fraction obtained from Tabernaemontana catharinensis. Parasitol Int. 2007;56:135–139
  26. Martín-Quintal Z, Del Rosario García-Miss M, Mut-Martín M, Matus-Moo A, Torres-Tapia LW, Peraza-Sánchez SR. The leishmanicidal effect of (3S)-16,17-didehydrofalcarinol, an oxylipin isolated from Tridax procumbens, is independent of NO production. Phytother Res. 2009;[Epub ahead of print]
  27. Ahmed S, Colmenares M, Soong L, Goldsmith-Pestana K, Munstermann L, Molina R, et al. Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis. Infect Immun. 2003;71:401–410
  28. Ganguly S, Das NK, Panja M, Pal S, Modak D, Rahaman M, et al. Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis. J Infect Dis. 2008;197:1762–1771
  29. Hailu A, van der Poll T, Berha N, Kager PA. Elevated plasma levels of interferon (IFN)-γ, IFN-γ inducing cytokines, and IFN-γ inducible CXC chemokines in visceral leishmaniasis. Am J Trop Med Hyg. 2004;71:561–567
  30. Tripathi P, Singh V, Naik S. Immune response to Leishmania: paradox rather than paradigm. FEMS Immunol Med Microbiol. 2007;51:229–242
  31. Arnoult D, Akarid K, Grodet A, Petit PX, Estaquier J, Ameisen JC. On the evolution of programmed cell death: apoptosis of the unicellular eukaryote Leishmania major involves cysteine proteinase activation and mitochondrion permeabilization. Cell Death Differ. 2002;9:65–81
  32. Haynes RK, Chan WC, Lung CM, Uhlemann AC, Eckstein U, Taramelli D. The Fe2+-mediated decomposition, PfATP6 binding, and antimalarial activities of artemisone and other artemisinins: the unlikelihood of C-centered radicals as bioactive intermediates. ChemMedChem. 2007;2:1480–1497
  33. Marquis JF, Gros P. Intracellular Leishmania: your iron or mine?. Trends Microbiol. 2007;15:93–95
  34. Das NK, Biswas S, Solanki S, Mukhopadhyay CK. Leishmania donovani depletes labile iron pool to exploit iron uptake capacity of macrophage for its intracellular growth. Cell Microbiol. 2009;11:83–94

PII: S0924-8579(10)00131-7

doi: 10.1016/j.ijantimicag.2010.03.008

International Journal of Antimicrobial Agents
Volume 36, Issue 1 , Pages 43-49 , July 2010

Article Tools

* Image Usage & Resolution